Department of Contact Lens, Sankara Nethralaya, Unit of Medical Research Foundation, Chennai, India.
Eye Contact Lens. 2023 Sep 1;49(9):374-378. doi: 10.1097/ICL.0000000000001007. Epub 2023 Jun 2.
To investigate the effect of front surface eccentricity (FSE) of scleral lenses (SLs) on corrected distance visual acuity (CDVA), contrast sensitivity (CS), and higher-order aberrations (HOAs) in keratoconic eyes.
Fifteen keratoconic eyes fitted with BostonSight SCLERAL lenses of different eccentricity values (FSE0=0, FSE1=0.30, and FSE2=0.60). CDVA, CS, and HOAs were measured at baseline and after 30 min of SL wear. CDVA and CS were measured with the Early Treatment Diabetic Retinopathy Study and Pelli-Robson chart, respectively, and iTrace aberrometer was used to evaluate the HOAs.
Baseline CDVA was 0.30±0.29, which significantly improved to 0.10±0.11, 0.05±0.06, and 0.05±0.08 logMAR with FSE0, FSE1, and FSE2, respectively ( P <0.05). The post hoc showed no significant difference between eccentricities. Baseline CS was 1.19±0.47, which improved to 1.54±0.12, 1.59±0.10, and 1.60±0.11 with FSE0, FSE1, and FSE2, respectively ( P <0.01), but post hoc showed no significant difference between eccentricities. A statistically significant reduction was found in HOAs when compared with baseline ( P <0.01). Comparison between eccentricities showed a significant difference only between FSE0 and FSE1 for RMS coma ( P =0.01) and RMS spherical aberrations ( P =0.004) where FSE1 showed better performance in reducing HOAs compared with FSE0. HO-RMS, RMS secondary astigmatism, and RMS trefoil showed no significant difference between eccentricities, but FSE1 and FSE2 performed superior to FSE0.
BostonSight SCLERAL lenses with varying eccentricities corrected a significant amount of HOAs and improved CDVA and CS in keratoconus patients. Practitioners should be aware of this distinct feature of SLs and use it as needed to improve visual performance.
研究巩膜镜片(SL)前表面偏心(FSE)对圆锥角膜眼矫正远距视力(CDVA)、对比敏感度(CS)和高阶像差(HOA)的影响。
对 15 只圆锥角膜眼分别使用不同偏心值(FSE0=0、FSE1=0.30 和 FSE2=0.60)的 BostonSight SCLERAL 镜片。在佩戴 SL 30 分钟前后分别测量 CDVA、CS 和 HOA。使用早期糖尿病视网膜病变研究和 Pelli-Robson 图表分别测量 CDVA 和 CS,使用 iTrace 像差仪评估 HOA。
基线时 CDVA 为 0.30±0.29,分别使用 FSE0、FSE1 和 FSE2 后,显著提高至 0.10±0.11、0.05±0.06 和 0.05±0.08 logMAR(P<0.05)。事后检验显示偏心度之间无显著差异。基线时 CS 为 1.19±0.47,分别使用 FSE0、FSE1 和 FSE2 后,提高至 1.54±0.12、1.59±0.10 和 1.60±0.11(P<0.01),但偏心度之间无显著差异。与基线相比,HOA 显著降低(P<0.01)。偏心度之间的比较仅在 RMS 彗差(P=0.01)和 RMS 球差(P=0.004)方面显示出 FSE1 与 FSE0 之间的显著差异,FSE1 与 FSE0 相比,降低 HOA 的效果更好。HO-RMS、RMS 二次散光和 RMS 三叶形无显著差异,但 FSE1 和 FSE2 优于 FSE0。
具有不同偏心度的 BostonSight SCLERAL 镜片可矫正大量 HOA,并改善圆锥角膜患者的 CDVA 和 CS。从业者应意识到 SL 的这一独特特征,并根据需要使用它来改善视觉性能。